WEIGHT-LOSS IN A MURINE CACHEXIA MODEL IS NOT ASSOCIATED WITH THE CYTOKINES TUMOR-NECROSIS-FACTOR-ALPHA OR INTERLEUKIN-6

被引:22
作者
MULLIGAN, HD
MAHONY, SM
ROSS, JA
TISDALE, MJ
机构
[1] UNIV ASTON,INST PHARMACEUT SCI,CRC EXPTL CHEMOTHERAPY GRP,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND
[2] UNIV EDINBURGH,ROYAL INFIRM EDINBURGH,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
关键词
CACHEXIA; TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; ANTI-TNF-ALPHA ANTIBODIES;
D O I
10.1016/0304-3835(92)90238-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Daily administration of an escalating dose of tumour necrosis factor-alpha (TNF-alpha) to female NMRI mice caused a progressive loss of body weight representing 12% of the original weight over a 6-day period. Weight loss was associated with a decreased food intake and pair-fed controls exhibited a weight loss of similar magnitude to that caused by TNF-alpha. However, weight loss in animals bearing a murine adenocarcinoma (MAC16) occurred without a change in energy intake and thus differed from that produced by TNF-alpha. Anti-TNF-alpha monoclonal antibodies at levels capable of protecting mice against lethal endotoxaemia were ineffective in reversing weight loss in animals bearing the MAC16 tumour and had no effect on the increase in tumour volume. Circulating levels of interleukin-6 were not elevated in animals bearing the MAC16 tumour and with a weight loss between 1.8 and 5.4 g. These results suggest that these cytokines are not involved in the cachexia produced by this murine tumour.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 21 条
[1]  
BALKWILL F, 1987, LANCET, V2, P1229
[2]   LIPOLYTIC FACTORS ASSOCIATED WITH MURINE AND HUMAN CANCER CACHEXIA [J].
BECK, SA ;
MULLIGAN, HD ;
TISDALE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (24) :1922-1926
[3]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[4]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[5]  
BIBBY MC, 1987, J NATL CANCER I, V78, P539
[6]   ELEVATED CIRCULATING INTERLEUKIN-6 IS ASSOCIATED WITH AN ACUTE-PHASE RESPONSE BUT REDUCED FIXED HEPATIC PROTEIN-SYNTHESIS IN PATIENTS WITH CANCER [J].
FEARON, KCH ;
MCMILLAN, DC ;
PRESTON, T ;
WINSTANLEY, FP ;
CRUICKSHANK, AM ;
SHENKIN, A .
ANNALS OF SURGERY, 1991, 213 (01) :26-31
[7]   FUNCTIONAL DISCRIMINATION BETWEEN INTERLEUKIN-6 AND INTERLEUKIN-1 [J].
HELLE, M ;
BOEIJE, L ;
AARDEN, LA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1535-1540
[8]   TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-ALPHA PRODUCTION IN CACHECTIC, TUMOR-BEARING MICE [J].
LONNROTH, C ;
MOLDAWER, LL ;
GELIN, J ;
KINDBLOM, L ;
SHERRY, B ;
LUNDHOLM, K .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) :889-896
[9]   METABOLIC EFFECTS OF TUMOR-NECROSIS-FACTOR ALPHA IN NMRI MICE [J].
MAHONY, SM ;
TISDALE, MJ .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :514-519
[10]   COMPARISON OF WEIGHT-LOSS INDUCED BY RECOMBINANT TUMOR NECROSIS FACTOR WITH THAT PRODUCED BY A CACHEXIA-INDUCING TUMOR [J].
MAHONY, SM ;
BECK, SA ;
TISDALE, MJ .
BRITISH JOURNAL OF CANCER, 1988, 57 (04) :385-389